title: Analysis of keratin polypeptides 8 and 19 variants in inflammatory bowel disease.
abstract: OBJECTIVE
  Keratin-8 (KRT8)-null mice develop spontaneous colitis and predisposition to liver injury. Human studies show that some KRT8 variants predispose to end-stage liver disease and progression and suggest that such variants might associate with UC or CD. We asked whether mutations in KRT8 or KRT19, the major intestinal keratins, are associated with UC/CD.
  
  
  METHODS
  Exonic regions of the KRT8/KRT19 genes were polymerase chain reaction-amplified using genomic DNA from 2 independent groups. Group I included 91 unrelated patients with CD, 93 unrelated patients with UC, and 70 unrelated/unaffected volunteers. KRT8 variants were also tested with pyrosequencing in Group II that included 682 independent nuclear families with both parents and at least 1 CD/UC-affected offspring and 273 unaffected controls. Both cohorts were enriched for familial IBD.
  
  
  RESULTS
  In Group I, KRT19 variants were identified in CD/UC patients within the promoter and exons 1+2, with similar mutation frequencies in the control/CD/UC groups. In contrast, 16 of 184 CD+UC patients harbored KRT8 heterozygous variants involving Gly62-to-Cys and Arg341-to-His and a novel Arg341-to-Cys, which were noted in 4 volunteers (Arg341-to-His) and correlated with extensive UC (P = .005). One family with unaffected parents had 3 pediatric-affected siblings with severe disease, 2 of whom are compound heterozygous (Gly62-to-Cys/Arg341-to-His). However, there was no significant departure from random transmission of the 3 alleles in Group II IBD families.
  
  
  CONCLUSIONS
  KRT8 and KRT19 variants are not overtransmitted or associated with familial IBD, although a potential role in sporadic IBD cannot be excluded. A novel but rare keratin-8 Arg341-to-Cys is identified in IBD patients.
authors.affiliation: Department of Medicine, Palo Alto Veterans Affairs Medical Center and Stanford University Digestive Disease Center, Palo Alto, California 94304, USA.
authors.forename: Guo-Zhong
authors.initials: GZ
authors.lastname: Tao
authors.forename: Pavel
authors.initials: P
authors.lastname: Strnad
authors.forename: Qin
authors.initials: Q
authors.lastname: Zhou
authors.forename: Ahmad
authors.initials: A
authors.lastname: Kamal
authors.forename: Leilei
authors.initials: L
authors.lastname: Zhang
authors.forename: Nahid D
authors.initials: ND
authors.lastname: Madani
authors.forename: Subra
authors.initials: S
authors.lastname: Kugathasan
authors.forename: Steven R
authors.initials: SR
authors.lastname: Brant
authors.forename: Judy H
authors.initials: JH
authors.lastname: Cho
authors.forename: M Bishr
authors.initials: MB
authors.lastname: Omary
authors.forename: Richard H
authors.initials: RH
authors.lastname: Duerr
mesh_terms: D000483:Alleles; D001706:Biopsy / Q000379:methods; D004247:DNA / Q000235:genetics*; D004591:Electrophoresis, Polyacrylamide Gel; D016099:Endoscopy, Gastrointestinal; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D015151:Immunoblotting; D015212:Inflammatory Bowel Diseases / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D053539:Keratin-19 / Q000235:genetics* / Q000378:metabolism; D053533:Keratin-8 / Q000235:genetics* / Q000378:metabolism; D009154:Mutation; D016133:Polymerase Chain Reaction; D011379:Prognosis
chemical_list: D053539:Keratin-19; D053533:Keratin-8; D004247:DNA